﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2024v5.2" xsi:schemaLocation="http://www.irs.gov/efile">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2025-10-29T12:27:14-07:00</ReturnTs>
    <TaxPeriodEndDt>2024-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>463590314</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>RUTH L BROOKS CPA</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>3207 PORMA</AddressLine1Txt>
        <CityNm>GRAND PRAIRIE</CityNm>
        <StateAbbreviationCd>TX</StateAbbreviationCd>
        <ZIPCd>75054</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2024-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>942733047</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>PAN AMERICAN OPHTHALMOLOGICAL FOUNDATION</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>PANA</BusinessNameControlTxt>
      <PhoneNum>8172757553</PhoneNum>
      <USAddress>
        <AddressLine1Txt>2504 W PARK ROW DRIVE SUITE B5 129</AddressLine1Txt>
        <CityNm>PANTEGO</CityNm>
        <StateAbbreviationCd>TX</StateAbbreviationCd>
        <ZIPCd>76013</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>TERESA J BRADSHAW</PersonNm>
      <PersonTitleTxt>EXECUTIVE DIRECTOR</PersonTitleTxt>
      <PhoneNum>8172757553</PhoneNum>
      <SignatureDt>2025-10-24</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>true</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>Ruth L Brooks CPA</PreparerPersonNm>
      <PTIN>P00534164</PTIN>
      <PhoneNum>8173602145</PhoneNum>
      <PreparationDt>2025-10-29</PreparationDt>
      <SelfEmployedInd>X</SelfEmployedInd>
    </PreparerPersonGrp>
    <TaxYr>2024</TaxYr>
    <BuildTS>2025-03-06 01:10:19Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="8">
    <IRS990 documentId="IRS990-01" referenceDocumentId="IRS990ScheduleO-01" softwareId="24020153">
      <PrincipalOfcrBusinessName>
        <BusinessNameLine1Txt>TERESA J BRADSHAW</BusinessNameLine1Txt>
      </PrincipalOfcrBusinessName>
      <USAddress>
        <AddressLine1Txt>1301 S BOWEN RD 450</AddressLine1Txt>
        <CityNm>ARLINGTON</CityNm>
        <StateAbbreviationCd>TX</StateAbbreviationCd>
        <ZIPCd>76013</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>832064</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.PAAO.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1973</FormationYr>
      <LegalDomicileStateCd>TX</LegalDomicileStateCd>
      <ActivityOrMissionDesc>THE PRIMARY PURPOSE IS TO PROMOTE THE DEVELOPMENT OF OPHTHALMOLOGY AND RELATED SCIENCES AMONG OPHTHLAMOLOGISTS IN THE WESTERN HEMISPHERE THROUGH SCHOLARSHIPS, SEMINARS AND PUBLICATIONS.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>19</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>18</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <TotalVolunteersCnt>0</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>228479</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>185360</CYContributionsGrantsAmt>
      <CYProgramServiceRevenueAmt>0</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>192585</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>171170</CYInvestmentIncomeAmt>
      <CYOtherRevenueAmt>0</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>421064</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>356530</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>143500</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>47250</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <CYSalariesCompEmpBnftPaidAmt>0</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>0</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>134576</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>76869</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>278076</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>124119</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>142988</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>232411</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>2650652</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>3036126</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>95079</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>45514</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>2555573</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>2990612</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>THE PRIMARY PURPOSE IS TO PROMOTE THE DEVELOPMENT OF OPHTHALMOLOGY AND RELATED SCIENCES AMONG OPHTHLAMOLOGISTS IN THE WESTERN HEMISPHERE THROUGH SCHOLARSHIPS, SEMINARS AND PUBLICATIONS.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>3000</ExpenseAmt>
      <GrantAmt>0</GrantAmt>
      <RevenueAmt>0</RevenueAmt>
      <Desc>PAN-AMERICAN RESEARCH DAY - THIS TAKES PLACE ONE DAY BEFORE THE ARVO MEETING EVERY YEAR AND OFFERS AN OPPORTUNITY FOR THE YOUNG RESEARCHERS TO PRESENT THE LATEST INFORMATION AND RESEARCH IN THE FIELD OF OPHTHALMOLOGY WITH AN EMPHASIS ON PARTICIPANTS FROM THE AMERICAS.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>1500</RevenueAmt>
        <Desc>ARVO/PAAO FELLOW ARE TRAVEL SCHOLARSHIPS THAT ARE AWARDED TO INDIVIDUALS WHO HAVE PRESENTED OR PUBLISHED RESEARCH PAPERS WHO WILL BE PRESENTING THEIR WORK AT THE ANNUAL ARVO MEETING. FINANCIAL NEED MST BE DEMONSTRATED.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>40000</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>40000</RevenueAmt>
        <Desc>GILLINGHAM FELLOWSHIP IS A FELLOWSHIP OFFERED TO QUALIFIED LATIN AMERICAN CANDIDATES IN A VARIETY OF SUB SPECIALTY INTEREST AT VARIOUS INSTITUTES IN THE UNITED STATES AND CANADA.</Desc>
      </ProgSrvcAccomActy3Grp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>1000</RevenueAmt>
        <Desc>LO MEJOR DE LA AAO EN ESPANOL - THIS IS A COURSE THAT WAS ESTABLISHED IN 1986 AND IS GIVEN ANNUALLY AFTER THE AMERICAN ACADEMY OF OPHTHALMOLOGY MEETING THAT HIGHLIGHTS THE EDUCATION OF THE AAO MEETING IN SPANISH.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>0</RevenueAmt>
        <Desc>TIM SEAR SCHOLARSHIP: PRESENTED TO OUTSTANDING STUDENTS WHO HAVE PRESENTED PAPERS OR PUBLISHED DURING THEIR TRAINING PERIOD AND SHOW THE POTENTIAL TO BE A FUTURE PROFESSOR OR LEADER IN OPHTHALMOLOGY.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>3250</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>3000</RevenueAmt>
        <Desc>ED-EMERGING COUNTRIES PROGRAMS FOCUS GROUP TO PROVIDE CONTINUING EDUCATION THROUGH TRAINING COURSES, EDUCATIONAL MATERIALS, LECTURES AND SCHOLARSHIPS FOR THOSE DEVELOPING COUNTRIES IN LATIN AMERICA.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>0</RevenueAmt>
        <Desc>LIONS/PAAO PREVENT BLINDNESS PROGRAM - THIS PROGRAM WAS ESTABLISHED TO STIMULATE PREVENTION OF BLINDNESS PROGRAMS IN THE AMERICAS.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>0</RevenueAmt>
        <Desc>ADVANCEMENT OF OPHTHALMIC CARE AND TO DECREASE THE INCIDENCE OF PREVENTABLE BLINDNESS IN THE WESTERN HEMISPHERE THROUGH SCHOLARSHIPS, SEMINARS AND PUBLICATIONS.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>0</RevenueAmt>
        <Desc>HAITI RELIEF PROJECT - THE PAAO ORGANIZED THE HAITI RELIEF PROGRAM IN RESPONSE TO THE DEVASTATING EARTHQUAKE THAT TOOK PLACE ON JANUARY 12, 2010. THE FIRST PHASE WAS TO PROVIDE THE HAITIAN SOCIETY OF OPHTHALMOLOGY WITH FIRST RESPONSE EMERGENCY KITS. FOR THE SECOND PHASE, THE PAAO HAITI RELIEFT PROGRAM WAS DESIGNED TO PROVIDE EDUCATIONAL TRAINING SCHOLARSHIPS.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>25000</RevenueAmt>
        <Desc>KAYSER GLOBAL AWARD IDENTIFIES LEADING VISUAL SCIENTISTS IN THE FOREFRONT OF INNOVATIVE CLINICAL AND BASIC SCIENCE RESEARCH IN OPHTHALMOLOGY AND RECOGNIZES WORK THAT HAS MADE A SIGNIFICANT NEW CONTRIBUTION TO KNOWLEDGE ABOUT IMPROVING VISION AND PREVENTION OF BLINDNESS.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>0</RevenueAmt>
        <Desc>THE TROUTMAN VERONNEAU PRIZE RECOGNIZES THE BEST WORK SUBMITTED BY AN OPHTHALMOLOGIST UNDER THE AGE OF 45, ALTERNATING BETWEEN CORNEA AND STRABISMUS AND PRESENTS THE WINNING PAPER AT THE PAAO CONGRESSES.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>0</RevenueAmt>
        <Desc>BFB AWARD - ADVANCEMENT OF OPHTHALMIC CARE AND TO DECREASE THE INCIDENCE OF PREVENTABLE BLINDNESS IN THE WESTERN HEMISPHERE THROUGH SCHOLARSHIPS, SEMINARS AND PUBLICATIONS.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>0</RevenueAmt>
        <Desc>SOPANOP SCHOLARSHIPS PROMOTE CONTINUING EDUCATION AND ADVANCED TRAINING IN OCULOPLASTICS.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>38434</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>0</RevenueAmt>
        <Desc>ALLOCATION OF OVERHEAD EXPENSES TO PROGRAM SERVICES</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>0</RevenueAmt>
        <Desc>LIANA &amp; MARCELO VENTURA FELLOWSHIP PROMOTES CONTINUING EDUCATION AND ADVANCED TRAINING WITH RESPECT TO OPHTHALMOLOGICAL DISEASE IN THE RETINA AND VITREOUS THAT AFFECT THE PEDICATRIC POPULATION IN A CLINICAL SETTING AT THE PEDIATRIC RETINA DEPARTMENT OF BASCOM PALMER EYE INSTITUTE OR ANOTHER EYE INSTITUTE.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>11000</RevenueAmt>
        <Desc>THE AREVALO YO PRIZE RECOGNIZES AN INDIVIDUAL WHO HAS DEMONSTRATED CARING &amp; SERVICE IN THEIR HOME COMMUNITY ABOVE &amp; BEYOND WHAT IS REQUIRED OR EXPECTED. THE PRIZE RECOGNIZES A YOUNG OPHTHALMOLOGIST PAAO MEMBER WHO HAS DEMONSTRATED PROMISE IN ACADEMICS &amp; HAS PUBLISHED &amp; PPRESENTED RELATIVELY EXTENSIVELY FOR HIS/HER AGE &amp; HAS PARTICIPATED IN LEADERSHIP ACTIVITIES.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>1000</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>5500</RevenueAmt>
        <Desc>RICH &amp; CHITA ABBOTT AWARD PROVIDES SUPPORT FOR EACH PAAOS LEADERSHIP DEVELOPMENT COURSE BY RECOGNIZING AND PRESENTING A PRIZE TO THE LDP PARTICIPANT FOR THEIR OUTSTANDING PROJECT.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>0</RevenueAmt>
        <Desc>ENRIQUE GRAUE WICERS AWARD FOR TRANSORMATION LEADERSHIP RECOGNIZES OPHTHALMOLOGISTS, WHO THROUGH A TRAJECTORY OF SEVERAL YEARS OF LEADERSHIP, HAVE BEEN KEY IN THE CREATION OR TRANSFORMATION OF OPHTHALMOLOGICAL INSTITUTIONS, HOSPITALS, AND/OR ASSOCIATIONS.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>0</RevenueAmt>
        <Desc>PYOTT FOUNDATION CONGRESS AWARD - RECOGNIZES YOUTH OPHTHALMOLOGISTS IN SCIENCE RESEARCH IN OPHTHALMOLOGY IN THE FIELD OF RETINA.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>1250</RevenueAmt>
        <Desc>BRENNAN LEADERSHIP SCHOLARSHIP - THE PURPOSE OF THE MICHAEL &amp; HELEN BRENNAN INTERNATIONAL LEADERSHIP SCHOLARSHIP PROGRAMS IS TO PROVIDE FINANCIAL AID TO YOUNG LEADERS TO PARTICIPATE IN THE PAAOS LEADERSHIP DEVELOPMENT COURSE.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>250</RevenueAmt>
        <Desc>VISITING PROFESSORS SCHOLARSHIPS - PROVIDES TRAVEL AWARDS TO LECTURE AT NATIONAL OPHTHALMOLOGICAL MEETINGS PROVIDING EDUCATION FOR THE ADVANCEMENT OF OPHTHALMIC CARE AND TO DECREASE THE INCIDENCE OF PREVENTABLE BLINDNESS IN THE WESTERN HEMISPHERE AND BEYOND.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>250</RevenueAmt>
        <Desc>THE BRONWYN BATEMAN AWARD FOR WOMENS LEADERSHIP IN OPHTHALMOLOGY - HIGHLIGHTS SIGNIFICANT ACCOMPLISHMENTS OF A FEMAIL OPHTHALMOLOGIST IN THE AREAS OF LEADERSHIP, EDUCATION, AND PUBLIC HEALTH CONTRIBUTIONS. THE RECIPIENT RECEIVES A PRIZE AT THE PAAOS BIENNIAL CONGRESSES.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>300</RevenueAmt>
        <Desc>ALVARO RODRIGUEZ TRAVEL AWARD - RECOGNIZES THE BEST WORK SUBMITTED BY AN OPHTHALMOLOGIST UNDER THE AGE OF 45, IN GLAUCOMA AND RETINA. THE WINNER RECEIVES A PRIZE AND PRESENTS THE WINNING PAPER AT THE PAAO CONGRESSES.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>41615</RevenueAmt>
        <Desc>BARRAQUER NAMED LECTURE - THE BARRAQUER NAMED LECTURE WAS ESTABLISHED BY THE BARRAQUER INSTITUTE AND ALUMNI TO HONOR PROFESSOR JOSE BERROCAL MONER. THE BARRAQUER NAMED LECTURE IS PRESENTED AT THE BIENNIAL PAAO CONGRESSES.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>30000</RevenueAmt>
        <Desc>THE JOSE AND PURU BERROCAL BEST PAPER PRIZE - RECOGNIZES THE BEST WORK SUBMITTED BY A YOUNG OPHTHALMOLOGIST, IN D RETINA. THE WINNER RECEIVES A PRIZE AND PRESENTS THE WINNING PAPER AT THE PAAO CONGRESSES.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>0</ExpenseAmt>
        <GrantAmt>0</GrantAmt>
        <RevenueAmt>500</RevenueAmt>
        <Desc>INDIVIDUAL RESTRICTED DONATION</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <TotalOtherProgSrvcExpenseAmt>42684</TotalOtherProgSrvcExpenseAmt>
      <TotalOtherProgSrvcGrantAmt>0</TotalOtherProgSrvcGrantAmt>
      <TotalOtherProgSrvcRevenueAmt>119665</TotalOtherProgSrvcRevenueAmt>
      <TotalProgramServiceExpensesAmt>85684</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="IRS990ScheduleA-01" referenceDocumentName="IRS990ScheduleA">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="IRS990ScheduleB-01" referenceDocumentName="IRS990ScheduleB">true</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="IRS990ScheduleD-01" referenceDocumentName="IRS990ScheduleD">false</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="IRS990ScheduleD-01" referenceDocumentName="IRS990ScheduleD">false</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="IRS990ScheduleD-01" referenceDocumentName="IRS990ScheduleD">false</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="IRS990ScheduleD-01" referenceDocumentName="IRS990ScheduleD">false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd referenceDocumentId="IRS990ScheduleD-01" referenceDocumentName="IRS990ScheduleD">false</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="IRS990ScheduleD-01" referenceDocumentName="IRS990ScheduleD">false</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="IRS990ScheduleD-01" referenceDocumentName="IRS990ScheduleD">false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="IRS990ScheduleD-01" referenceDocumentName="IRS990ScheduleD">false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="IRS990ScheduleD-01" referenceDocumentName="IRS990ScheduleD">false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="IRS990ScheduleD-01" referenceDocumentName="IRS990ScheduleD">true</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="IRS990ScheduleD-01" referenceDocumentName="IRS990ScheduleD">false</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="IRS990ScheduleD-01" referenceDocumentName="IRS990ScheduleD">false</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="IRS990ScheduleD-01" referenceDocumentName="IRS990ScheduleD">false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="IRS990ScheduleF-01" referenceDocumentName="IRS990ScheduleF">false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="IRS990ScheduleF-01" referenceDocumentName="IRS990ScheduleF">false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd referenceDocumentId="IRS990ScheduleF-01" referenceDocumentName="IRS990ScheduleF">true</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>false</FundraisingActivitiesInd>
      <GamingActivitiesInd>false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="IRS990ScheduleI-01" referenceDocumentName="IRS990ScheduleI">true</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="IRS990ScheduleI-01" referenceDocumentName="IRS990ScheduleI">true</GrantsToIndividualsInd>
      <ScheduleJRequiredInd>false</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd referenceDocumentId="IRS990ScheduleR-01" referenceDocumentName="IRS990ScheduleR">false</DisregardedEntityInd>
      <RelatedEntityInd referenceDocumentId="IRS990ScheduleR-01" referenceDocumentName="IRS990ScheduleR">true</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd referenceDocumentId="IRS990ScheduleR-01" referenceDocumentName="IRS990ScheduleR">false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd referenceDocumentId="IRS990ScheduleR-01" referenceDocumentName="IRS990ScheduleR">false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>0</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <EmployeeCnt>0</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>true</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>false</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>19</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>18</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>false</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>true</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>true</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>true</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>false</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>TERESA J BRADSHAW</PersonNm>
        <PhoneNum>8177272334</PhoneNum>
        <USAddress>
          <AddressLine1Txt>2504 W PARK FOW DRIVE SUITE B5 129</AddressLine1Txt>
          <CityNm>ARLINGTON</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>76013</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <NoListedPersonsCompensatedInd>X</NoListedPersonsCompensatedInd>
      <Form990PartVIISectionAGrp>
        <PersonNm>SEE ATTACHED</PersonNm>
        <TitleTxt>DIRECTORS</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>false</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <FederatedCampaignsAmt>185360</FederatedCampaignsAmt>
      <TotalContributionsAmt>185360</TotalContributionsAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>112384</TotalRevenueColumnAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>112384</ExclusionAmt>
      </InvestmentIncomeGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>534320</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>475534</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>58786</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>58786</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>58786</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>0</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>356530</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>58786</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>112384</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>47250</TotalAmt>
        <ProgramServicesAmt>47250</ProgramServicesAmt>
      </GrantsToDomesticIndividualsGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>12700</TotalAmt>
        <ProgramServicesAmt>6350</ProgramServicesAmt>
        <ManagementAndGeneralAmt>6350</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </FeesForServicesAccountingGrp>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>18339</TotalAmt>
        <ProgramServicesAmt>9170</ProgramServicesAmt>
        <ManagementAndGeneralAmt>9169</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <InsuranceGrp>
        <TotalAmt>2290</TotalAmt>
        <ProgramServicesAmt>1145</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1145</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>CREDIT CARD FEES</Desc>
        <TotalAmt>1713</TotalAmt>
        <ProgramServicesAmt>856</ProgramServicesAmt>
        <ManagementAndGeneralAmt>857</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>MISCELLANEOUS</Desc>
        <TotalAmt>20</TotalAmt>
        <ProgramServicesAmt>10</ProgramServicesAmt>
        <ManagementAndGeneralAmt>10</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>BOARD OF DIRECTOR MEETINGS</Desc>
        <TotalAmt>4531</TotalAmt>
        <ProgramServicesAmt>2266</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2265</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>37276</TotalAmt>
        <ProgramServicesAmt>18637</ProgramServicesAmt>
        <ManagementAndGeneralAmt>18639</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>124119</TotalAmt>
        <ProgramServicesAmt>85684</ProgramServicesAmt>
        <ManagementAndGeneralAmt>38435</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>220423</BOYAmt>
        <EOYAmt>159121</EOYAmt>
      </CashNonInterestBearingGrp>
      <AccountsReceivableGrp>
        <BOYAmt>1075</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </AccountsReceivableGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>2353933</BOYAmt>
        <EOYAmt>2793749</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>75221</BOYAmt>
        <EOYAmt>83256</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>2650652</BOYAmt>
        <EOYAmt>3036126</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>62000</BOYAmt>
        <EOYAmt>45514</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>33079</BOYAmt>
        <EOYAmt>0</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>95079</BOYAmt>
        <EOYAmt>45514</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>1278771</BOYAmt>
        <EOYAmt>1569082</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>1276802</BOYAmt>
        <EOYAmt>1421530</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>2555573</BOYAmt>
        <EOYAmt>2990612</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>2650652</BOYAmt>
        <EOYAmt>3036126</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <InfoInScheduleOPartXIInd>X</InfoInScheduleOPartXIInd>
      <ReconcilationRevenueExpnssAmt>232411</ReconcilationRevenueExpnssAmt>
      <OtherChangesInNetAssetsAmt>202628</OtherChangesInNetAssetsAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <ConsolAndSepBasisFinclStmtInd>X</ConsolAndSepBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>true</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="IRS990ScheduleA-01" softwareId="24020153">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <OtherSupportSumAmt>0</OtherSupportSumAmt>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>169595</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>85879</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>77833</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>228479</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>185360</CurrentTaxYearAmt>
        <TotalAmt>747146</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TaxRevLeviedOrgnztnlBnft170Grp>
        <TotalAmt>0</TotalAmt>
      </TaxRevLeviedOrgnztnlBnft170Grp>
      <GovtFurnSrvcFcltsVl170Grp>
        <TotalAmt>0</TotalAmt>
      </GovtFurnSrvcFcltsVl170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>169595</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>85879</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>77833</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>228479</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>185360</CurrentTaxYearAmt>
        <TotalAmt>747146</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>0</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>747146</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>-68297</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>148761</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>120451</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>148761</CurrentTaxYearMinus1YearAmt>
        <TotalAmt>349676</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <UnrelatedBusinessNetIncm170Grp>
        <TotalAmt>0</TotalAmt>
      </UnrelatedBusinessNetIncm170Grp>
      <OtherIncome170Grp>
        <TotalAmt>0</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>1096822</TotalSupportAmt>
      <PublicSupportCY170Pct>0.68120</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.61580</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
      <PublicSupportTotal509Amt>0</PublicSupportTotal509Amt>
      <PublicSupportCY509Pct>0</PublicSupportCY509Pct>
      <InvestmentIncomeCYPct>0</InvestmentIncomeCYPct>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="IRS990ScheduleB-01">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="IRS990ScheduleD-01" softwareId="24020153">
      <OtherLiabilitiesOrgGrp>
        <Desc>DUE TO RELATED PARTY</Desc>
        <Amt>0</Amt>
      </OtherLiabilitiesOrgGrp>
      <TotalLiabilityAmt>0</TotalLiabilityAmt>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="IRS990ScheduleF-01" softwareId="24020153">
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>FELLOWSHIP (GILLIGHAM)</TypeOfAssistanceTxt>
        <RegionTxt>Central America</RegionTxt>
        <RecipientCnt>2</RecipientCnt>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>GRANT (ARNO HABICHT)</TypeOfAssistanceTxt>
        <RegionTxt>South America</RegionTxt>
        <RecipientCnt>3</RecipientCnt>
      </ForeignIndividualsGrantsGrp>
      <ForeignIndividualsGrantsGrp>
        <TypeOfAssistanceTxt>PYOTT TRAVEL AWARD</TypeOfAssistanceTxt>
        <RegionTxt>South America</RegionTxt>
        <RecipientCnt>2</RecipientCnt>
      </ForeignIndividualsGrantsGrp>
      <TransferToForeignCorpInd>false</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>false</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>false</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>false</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>false</ForeignPartnershipInd>
      <BoycottCountriesInd>false</BoycottCountriesInd>
    </IRS990ScheduleF>
    <IRS990ScheduleI documentId="IRS990ScheduleI-01" softwareId="24020153">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
    </IRS990ScheduleI>
    <IRS990ScheduleO documentId="IRS990ScheduleO-01" softwareId="24020153">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Pt VI, Line 19</FormAndLineReferenceDesc>
        <ExplanationTxt>EACH ANNUAL INFORMATION RETURN IS AVAILABLE FOR A PERIOD OF THREE YEARS UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Pt XI</FormAndLineReferenceDesc>
        <ExplanationTxt>INCREASE IN CSV OF LIFE INSURANCE</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Pt VI, Line 11b</FormAndLineReferenceDesc>
        <ExplanationTxt>990 IS REVIEWED BY THE ADMINISTRATIVE OFFICER.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Pt VI, Line 12c</FormAndLineReferenceDesc>
        <ExplanationTxt>ONE OF THE BOARD MEMBERS HAS BEEN ASSIGNED TO MONITOR DISCOSURES AND ENFORCE COMPLIANCE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Pt XI</FormAndLineReferenceDesc>
        <ExplanationTxt>INCREASE IN CASH SURRENDER VALUE OF LIFE INSURANCE $7,398</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Pt XI</FormAndLineReferenceDesc>
        <ExplanationTxt>UNREALIZED GAINS ON INVESTMENTS $73,309</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>LO MEJOR DE LA AAO EN ESPANOL - THIS IS A COURSE THAT WAS 0. 0. 1000.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>TIM SEAR SCHOLARSHIP: PRESENTED TO OUTSTANDING STUDENTS 0. 0. 0.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>ED-EMERGING COUNTRIES PROGRAMS FOCUS GROUP TO PROVIDE 3250. 0. 3000.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>LIONS/PAAO PREVENT BLINDNESS PROGRAM - THIS PROGRAM 0. 0. 0.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>ADVANCEMENT OF OPHTHALMIC CARE AND TO DECREASE THE INCIDENCE 0. 0. 0.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>HAITI RELIEF PROJECT - THE PAAO ORGANIZED THE HAITI 0. 0. 0.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>KAYSER GLOBAL AWARD IDENTIFIES LEADING VISUAL SCIENTISTS 0. 0. 25000.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>THE TROUTMAN VERONNEAU PRIZE RECOGNIZES THE BEST WORK 0. 0. 0.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>BFB AWARD - ADVANCEMENT OF OPHTHALMIC CARE AND TO DECREASE THE 0. 0. 0.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>SOPANOP SCHOLARSHIPS PROMOTE CONTINUING EDUCATION 0. 0. 0.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>ALLOCATION OF OVERHEAD EXPENSES TO PROGRAM SERVICES 38434. 0. 0.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>LIANA &amp; MARCELO VENTURA FELLOWSHIP PROMOTES CONTINUING 0. 0. 0.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>THE AREVALO YO PRIZE RECOGNIZES AN INDIVIDUAL WHO HAS 0. 0. 11000.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>RICH &amp; CHITA ABBOTT AWARD PROVIDES SUPPORT FOR EACH 1000. 0. 5500.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>ENRIQUE GRAUE WICERS AWARD FOR TRANSORMATION LEADERSHIP 0. 0. 0.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>PYOTT FOUNDATION CONGRESS AWARD - RECOGNIZES YOUTH 0. 0. 0.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>BRENNAN LEADERSHIP SCHOLARSHIP - THE PURPOSE OF THE 0. 0. 1250.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>VISITING PROFESSORS SCHOLARSHIPS - PROVIDES TRAVEL 0. 0. 250.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>THE BRONWYN BATEMAN AWARD FOR WOMENS LEADERSHIP IN 0. 0. 250.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>ALVARO RODRIGUEZ TRAVEL AWARD - RECOGNIZES THE BEST 0. 0. 300.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>BARRAQUER NAMED LECTURE - THE BARRAQUER NAMED LECTURE WAS 0. 0. 41615.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>THE JOSE AND PURU BERROCAL BEST PAPER PRIZE - RECOGNIZES 0. 0. 30000.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part III, Line 4d</FormAndLineReferenceDesc>
        <ExplanationTxt>INDIVIDUAL RESTRICTED DONATION 0. 0. 500.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part IX, Line 24e</FormAndLineReferenceDesc>
        <ExplanationTxt>FUNDRAISING CULTIVATION 7365. 3682. 3683. 0.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part IX, Line 24e</FormAndLineReferenceDesc>
        <ExplanationTxt>RECOGNITION GRANTS/DONATIONS 1000. 500. 500. 0.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part IX, Line 24e</FormAndLineReferenceDesc>
        <ExplanationTxt>eLEARNING COURSES/WEBINARS 2944. 1472. 1472. 0.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>Form 990, Part IX, Line 24e</FormAndLineReferenceDesc>
        <ExplanationTxt>EDUCATIONAL MEETINGS &amp; PROGRAMS 25967. 12983. 12984. 0.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="IRS990ScheduleR-01" softwareId="24020153">
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>PAN AMERICAN ASSOCIATION OF OPHTHALMOLOGY</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>1301 S BOWEN ROAD SUITE 450</AddressLine1Txt>
          <CityNm>ARLINGTON</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>76013</ZIPCd>
        </USAddress>
        <EIN>620564302</EIN>
        <PrimaryActivitiesTxt>ASSOC OF OPHTHALMOLOGISTS</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>TN</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501(C)(6)</ExemptCodeSectionTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>NA</BusinessNameLine1Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>false</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <ReceiptOfIntAnntsRntsRyltsInd>false</ReceiptOfIntAnntsRntsRyltsInd>
      <GiftGrntOrCapContriToOthOrgInd>false</GiftGrntOrCapContriToOthOrgInd>
      <GiftGrntCapContriFromOthOrgInd>false</GiftGrntCapContriFromOthOrgInd>
      <LoansOrGuaranteesToOtherOrgInd>false</LoansOrGuaranteesToOtherOrgInd>
      <LoansOrGuaranteesFromOthOrgInd>false</LoansOrGuaranteesFromOthOrgInd>
      <DivRelatedOrganizationInd>false</DivRelatedOrganizationInd>
      <AssetSaleToOtherOrgInd>false</AssetSaleToOtherOrgInd>
      <AssetPurchaseFromOtherOrgInd>false</AssetPurchaseFromOtherOrgInd>
      <AssetExchangeInd>false</AssetExchangeInd>
      <RentalOfFacilitiesToOthOrgInd>false</RentalOfFacilitiesToOthOrgInd>
      <RentalOfFcltsFromOthOrgInd>false</RentalOfFcltsFromOthOrgInd>
      <PerformOfServicesForOthOrgInd>false</PerformOfServicesForOthOrgInd>
      <PerformOfServicesByOtherOrgInd>false</PerformOfServicesByOtherOrgInd>
      <SharingOfFacilitiesInd>false</SharingOfFacilitiesInd>
      <PaidEmployeesSharingInd>false</PaidEmployeesSharingInd>
      <ReimbursementPaidToOtherOrgInd>false</ReimbursementPaidToOtherOrgInd>
      <ReimbursementPaidByOtherOrgInd>false</ReimbursementPaidByOtherOrgInd>
      <TransferToOtherOrgInd>false</TransferToOtherOrgInd>
      <TransferFromOtherOrgInd>false</TransferFromOtherOrgInd>
    </IRS990ScheduleR>
  </ReturnData>
</Return>